We previously reported that overexpression of the 24 kDa basic fibroblast factor (or FGF-2) isoform provides protection from the cytotoxic effect of ionizing radiation (IR). DNA double-strand breaks (DSB), the IR-induced lethal lesions, are mainly repaired in human cells by non-homologous end joining system (NHEJ). NHEJ reaction is dependent on the DNA-PK holoenzyme (composed of a regulatory sub-unit, Ku, and a catalytic sub-unit, DNA-PKcs) that assembles at sites of DNA damage. We demonstrated here that the activity of DNA-PK was increased by twofold in two independent radioresistant cell lines, HeLa 3A and CAPAN A3, overexpressing the 24 kDa FGF-2. This increase was associated with an overexpression of the DNA-PKcs without modification of Ku expression or activity. This overexpression was due to an up-regulation of the DNAPKcs gene transcription by the 24 kDa FGF-2 isoform. Finally, HeLa 3A cells exhibited the hallmarks of phenotypic changes associated with the overexpression of an active DNA-PKcs. Indeed, a faster repair rate of DSB and sensitization to IR by wortmannin was observed in these cells. Our results represent the characterization of a new mechanism of control of DNA repair and radioresistance in human tumor cells dependent on the overproduction of the 24 kDa FGF-2 isoform.
Introduction
Basic fibroblast growth factor (FGF-2) belongs to a family of potent mitogens. FGF-2 is present in four different isoforms in most producer cell types (Renko et al., 1990) . These different isoforms are due to an alternative initiation of translation of a single mRNA either at an AUG codon (18 kDa form) or at three different upstream CUG codons (24, 21.5 and 21 kDa forms) (Prats et al., 1989) . The CUG-initiated forms contain an amino-terminal sequence responsible for nuclearisation of these proteins (Bugler et al., 1991) whereas the 18 kDa form remains mainly cytoplasmic (Bugler et al., 1991; Renko et al., 1990) . While the 18 kDa isoform can be externalized and acts via specific cell surface receptors, the CUG-initiated forms modulate cell proliferation by an intracellular mechanism independent of membrane receptors (Bikfalvi et al., 1995) . Several lines of evidence indicate that FGF-2 may provide protection from the cytotoxic effects of ionizing radiation (IR). For example, addition of exogenous FGF-2 protects bovine endothelial cells from IR-induced toxicity (Fuks et al., 1994) . Involvement of FGF-2 in the cellular response to IR is of clinical importance in primary human brain tumors, since FGF-2 appears to be more abundant in tumors that exhibit a poor response to radiation therapy (Takahashi et al., 1990) . The different isoforms of FGF-2 are not equally involved in this radioprotective effect. Indeed, we have previously demonstrated that when HeLa cells were transfected with mutated FGF-2 cDNA encoding the different FGF-2 isoforms, cells constitutively expressing the 24 kDa FGF-2 form showed increased radioresistance (HeLa 3A cells) while expressing the 18 kDa FGF-2 isoform (HeLa 5A) did not modify the survival after irradiation of HeLa cells. Acquisition of radioresistance was associated with an enrichment of cells in the G2 cell cycle phase after irradiation with hyperphosphorylation of the cyclin-dependent kinase p34cdc2 (Cohen-Jonathan et al., 1997) . However, the precise mechanism of the 24 kDa FGF-2 isoform radioprotective effect is not yet clearly understood.
DNA double strand breaks (DSB) are the principal lethal lesions induced by IR and radio-mimetic chemicals such as bleomycin. A variety of deleterious consequences can result from a misrepaired or an unrepaired DSB, including cell death, small deletions that can inactivate a single gene leading to impaired cell function, or chromosomal translocations. In the light of the dangers associated with DSB, highly efficient mechanisms have evolved for their recognition and repair. Mammalian cells appear to rejoin the majority of their DSB by a mechanism(s) of nonhomologous end joining (NHEJ) (Jeggo, 1998; Smith and Jackson, 1999) . Recent evidences show that the DNA dependent protein kinase (DNA-PK), XRCC4 and ligase IV, plays a central role in this repair pathway. DNA-PK, an heterotrimeric complex, is composed of a large catalytic subunit of 460 kDa (DNA-PKcs), a serine/threonine kinase that belongs to the phosphatidylinositol 3 kinase family (Hartley et al., 1995) , and a regulatory component consisting of the Ku86 and Ku70 proteins (Gottlieb and Jackson, 1993) . Ku70 and Ku86 proteins form an heterodimer (Mimori and Hardin, 1986 ) that binds to the DNA ends of DSB, then recruits and activates the catalytic subunit of the complex (Gottlieb and Jackson, 1993) . Once bound to the DNA end, the active DNA-PK complex acquires the capacity to phosphorylate many DNA bound proteins in the vicinity (Anderson and Carter, 1996) . Kinase activity is required for DNA-PKcs to be effective in cellular end-joining but the biologically relevant substrates are not yet known (Kurimasa et al., 1999) . Mice with deletions of genes for DNA-PKcs or Ku are hypersensitive to IR due to DSB repair defects and lack mature lymphocytes due to their inability to repair DSB formed during the assembly of the V(D)J segments of antigen receptor gene (Gao et al., 1998a; Ouyang et al., 1997; Zhu et al., 1996) .
Two other factors that form a tight complex in cells, XRCC4 and ligase IV, are also required for end joining of DSB in DNA. In addition to decreased radiation resistance and lymphomagenesis, mice with deletions for XRCC4 and ligase IV are embryonically lethal and exhibit neuronal apoptosis (Frank et al., 1998; Gao et al., 1998b) . Taken together, these data clearly demonstrate that the NHEJ pathway is involved in the cellular response of mammalian cells to the repair of IR-induced DSB.
The aim of our study was to determine whether DNA repair mechanisms and more particularly the NHEJ process is involved in the acquisition of cellular resistance to IR induced by the expression of the 24 kDa FGF-2 isoform in HeLa cells. We demonstrate here that the 24 kDa FGF-2 induced radioresistance is associated with an overexpression of the catalytic subunit of the DNA-PK complex in an active form leading to an accelerated kinetics of DNA repair.
Results

DNA-PK activity is increased in cells overexpressing the 24 kDa isoform of FGF-2
We first determined if the radioprotective effect of the 24 kDa FGF-2 isoform might be due to an increased activity of the whole DNA-PK complex. DNA-PK activity was quantified in cell extracts using the 'pull down assay' as previously described (Finnie et al., 1995; Muller et al., 1998b) . As shown in Figure 1a , DNA-PK activity was significantly increased by 1.8+0.27-fold (P50.05) in extracts from the HeLa 3A cells compared with extracts from the parental HeLa PINA cells. Because this result could not formally exclude a clonal variation of DNA-PKcs expression in this particular HeLa clone, we then analysed the effect of 24 kDa FGF-2 expression in another cell line. A similar increase in DNA-PK activity was observed in human pancreatic cells, CAPAN A3, that overexpressed the 24 kDa FGF-2 isoform (Estival et al., 2001 ) and presented a radioresistant phenotype (MID=4.28+0.45 Gy for CAPAN A3 cells and 2.68+0.28 Gy for CAPAN-1 cells, P50.01) (data not shown) as compared to the empty vector transfected CAPAN-1 cells (Figure 1a) . We have previously demonstrated that overexpression of the 18 kDa isoform of FGF-2 in HeLa cells (HeLa 5A) is not associated with an increased resistance to IR (Cohen-Jonathan et al., 1997) . Interestingly, no modification of DNA-PK activity was observed in HeLa 5A cells as compared to HeLa PINA cells ( Figure 1a) . Thus, increase in DNA-PK activity was observed in two independent cell lines that exhibited a radioresistant phenotype associated with 24 kda FGF-2 isoform overexpression.
The increase in DNA-PK activity is due to the overexpression of DNA-PKcs
We then evaluated the mechanism responsible for the observed increase in DNA-PK activity in HeLa 3A and CAPAN A3 cells. First, the activity of the regulatory subunit of DNA-PK, the Ku heterodimer, was assessed. Indeed, Ku DNA binding represents the predominant, if only, mechanism for DNA-PK activation because the Ku-defective mutants have undetectable DNA-PK activity (Finnie et al., 1995) . Ku DNA ends binding activity can be detected easily by using double-stranded DNA fragments in an electrophoretic mobility shift assay (EMSA) as previously described (Muller et al., 1998c; Zhang and Yaneva, 1992) . As shown in Figure 1b , no difference in Ku DNA ends binding activity was observed between the parental cell lines (HeLa PINA and CAPAN-1 cells) and the 24 kDa FGF-2 transfected cell lines (HeLa 3A and CAPAN A3). The lack of difference in Ku activity was also found with various amounts of protein extracts (data not shown).
Western blot analyses were then performed to determine whether variations in DNA-PKcs protein expression could account for the DNA-PK activity modifications in the 24 kDa FGF-2 expressing cells. As shown in Figure 2 , the expression of DNA-PKcs was significantly enhanced in HeLa 3A and CAPAN A3 cells compard to their respective controls. The factor of overexpression was 1.97+0.16-fold in HeLa 3A compared to HeLa PINA cells and 1.8+0.05-fold in CAPAN-3A compared to CAPAN-1 (P50.01). By contrast, as expected from the results of EMSA assays, FGF-2 induced radioresistance and DNA-PKcs upregulation I Ader et al no modification of Ku70 and Ku86 levels of expression was detected in the same cell extracts. In addition, the levels of expression of XRCC4 and ligase IV, two proteins also involved in the NHEJ reaction, were similar between 24 kDa FGF-2 expressing and control cells (data not shown). Thus, the overexpression of the 24 kDa FGF-2 isoform in two different radioresistant cell lines induces an overexpression of an active DNAPKcs.
Overexpression of DNA-PKcs protein is regulated at the transcription level
We then investigated the molecular mechanism involved in the up-regulation of DNA-PKcs expression. The DNA-PKcs mRNA level in radioresistant HeLa 3A and radiosensitive HeLa PINA cells was determined by RNAses Protection Assays (RPA) using the ribosomal protein mRNA 36B4 as constant probe (Laborda, 1991) (Figure 3 ). As shown in Figure 3a ,b, the amount of DNA-PKcs mRNA was increased by about fourfold in HeLa 3A cells as compared to control cells. To determine if the increase of DNAPKcs mRNA was due to the stimulation of DNA-PKcs gene transcription by the 24 kDa FGF-2 isoform, we transfected the two cell lines by reporter constructs encoding luciferase under the control of the human DNA-PKcs promoter (Connelly et al., 1998) . Expression of the 24 kDa FGF-2 isoform resulted in a The 24 kDa FGF-2 expression stimulates DSB repair kinetic
We next examined if this increase in DNA-PK activity was related to a higher rate of double-strand breaks DNA repair in 24 kDa FGF-2 transfected cells. The amount of DSB was measured by the FAR assay (see Materials and methods). Both radioresistant 24 kDa FGF-2 (HeLa 3A) and radiosensitive empty vector (HeLa PINA) transfected cells were labeled with [ 3 H]thymidine, then irradiated at 30 Gy to quantify the amount of DSB immediately after irradiation by determining the FAR. No significant difference in the amount of DSB immediately after irradiation between radioresistant (0.40+0.5) and radiosensitive cell lines (0.36+0.4) was found. We then determined the DNA DSB repair activity in these two cell lines by measuring the percentage of FAR remaining versus time after exposure to 30 Gy. As shown in Figure 4 , the rate of DSB repair was faster in the resistant HeLa 3A cells compared to the sensitive HeLa PINA cells. Sixty minutes after irradiation the percentage of FAR remaining in HeLa 3A cells dropped to 21% whereas almost 240 min were necessary to observe the same percentage in HeLa PINA cells. Moreover, DNA DSB were almost completely repaired in HeLa 3A cells 2 h after irradiation (percentage of FAR remaining after 2 h=6.1+2.84% versus 3.36+0.72% after 4 h) while a significant amount of DSB were still detectable in HeLa PINA cells 4 h after irradiation (percentage of FAR remaining 4 h after irradiation 14+5.6%). Similar results were obtained with an irradiation dose of 20 Gy (data not shown). These results indicate that the increase in DNA-PKcs expression and activity observed in radioresistant HeLa 3A cells is concomitant with an increased capacity to repair IR-induced DSB as compared to the control cells, HeLa PINA. 
Wortmannin reverses the 24 kDa FGF-2-induced radioresistance
To further assess the link between DNA-PK overexpression and FGF-2 induced radioresistance, we performed experiments using wortmannin, an inhibitor of PI-3 kinases. Wortmannin is a fungal metabolite that has been shown to be a potent and selective inhibitor of the p110 subunit of phosphatidylinositol-3-kinase (PI-3K) (Okada et al., 1994) . On the basis of similarity between the kinase domains of DNA-PK and PI-3K, it has been established that wortmannin is able to inhibit DNA-PK function in vitro but the IC50 for wortmannin toward DNA-PK is 250 -500 nM, i.e. clearly higher than the IC50 for inhibition of PI 3 kinase (1 -5 nM) (Hartley et al., 1995) . Nevertheless, wortmannin in combination with radiation was shown to be an effective radiosensitizer of murine and human cell lines (Price and Youmell, 1996; Sarkaria et al., 1998) with concomitant inhibition in treated cells of DSB, but not SSB repair (Boulton et al., 1996) . As previously described for HeLa cells (Price and Youmell, 1996) wortmannin treatment induced a slight but significant radiosensitization of empty vector transfected HeLa cells (MID=3.82+ 0.19 Gy versus 3.23+0.13 Gy for wortmannin treated cells; P50.02) ( Figure 5 ). More interestingly, the radioresistance of HeLa 3A cells was reduced by almost twofold by the same treatment (MID=6.58+0.21 Gy for HeLa 3A cells versus 3.53+0.28 Gy for wortmannin treated HeLa 3A; P50.001) ( Figure 5 ). In both cell lines, the concentration of wortmannin used in the experiments failed to modify cell survival by itself (data not shown). Moreover, treatment of HeLa 3A cells with wortmannin at 25 nM, known to inhibit PI-3K, did not induce radiosensitization of the cells (data not shown). These results support the involvement of the DNA-PK activity in the regulation of 24 kDa FGF-2 induced HeLa cells radioresistance.
Discussion
We have previously reported that transfection of the 24 kDa FGF-2 isoform led to an increase in cell survival after exposure to IR (Cohen-Jonathan et al., 1997) although the molecular mechanisms underlying this effect remained poorly understood. We demonstrate here, in two independent cell lines (HeLa 3A and CAPAN A3), that transfection of the 24 kDa FGF-2 isoform upregulates expression of an enzymatically active DNA-PKcs as compared with control cells. Interestingly, this effect was specific of the 24 kDa isoform of FGF-2 since no modification of DNA-PK activity was observed in the radiosensitive HeLa 5A cells overexpressing the 18 kDa isoform of FGF-2 (see Figure 1a ). According to the literature, the increase in DNA-PK activity is likely to explain the observed radioresistant phenotype. Indeed, accumulating evidence from a series of mutational and biochemical experiments demonstrate that both components of the DNA-PK complex (Ku 86, K70 and DNA-PKcs) are important for the repair of DSB in vivo. Mice with deletions of gene for DNA-PKcs are hypersensitive to IR due to a decreased ability to repair DSB and the kinase activity itself is required for the role of DNAPKcs in cellular end joining. Recently, few reports established that even in cells containing functional DNA-PK, a further increase in DNA-PK activity provides protection from DNA damaging agents. For example, we have previously demonstrated that an increase in DNA-PK activity participates in the stage of drug-therapy resistant disease in patients with chronic lymphocytic leukemia (Muller et al., 1998c) . Similarly, acquired resistance to adriamycin and other DNA damaging agents in an HL60 cell line was shown to be due to a threefold increase in DNA-PK enzyme activity (Shen et al., 1998a) . Finally, exposure of cells to nitric oxide results in a 2 -4-fold increase in DNA-PK activity and protects cells from DNA-damaging anti-tumor agents including IR (Xu et al., 2000) . Our results strongly suggest here that even a slight (twofold) stimulation of DNA-PK activity can be sufficient to induce a radioresistant phenotype. Interestingly, the 24 kDa FGF-2 mediated increase in DNA-PK activity does not appear to be further regulated by exposure to IR since no modification of its level of expression or activity was observed in HeLa cells up to 2 h after exposure to 30 Gy (data not shown). In addition to the well-described role of DNA-PK in the cellular response to IR, there are further arguments suggesting that the increase in DNA-PK activity explains the observed radioresistant phenotype. First, we observed a higher repair rate of DSB in HeLa 3A as compared to HeLa PINA cells that is likely to Figure 5 The DNA-PK inhibitor, wortmannin inhibits 24 kDa FGF-2 induced radioresistance. HeLa PINA and HeLa 3A cells were exposed to either solvent (DMSO) or 20 mM wortmannin for 2 h and irradiated at different doses. The medium was changed 16 h later and the surviving fraction calculated as described in Materials and methods. Data points are means+s.d. from three independent trials reflect an increase in the NHEJ process in intact cells. Accumulating evidence showed that this repair pathway is largely predominant in mammalian cells. For example, when cells are engineered with DNA chromosomal substrates that permit the repair of DSB by either homologous recombination or by NHEJ, the great majority of the joining events occurs by NHEJ (Godwin et al., 1994; Sargent et al., 1997) . Secondly, the fact that HeLa 3A cells are specifically sensitized to the killing effect of IR by wortmannin also suggests a role for DNA-PK in the radioresistant phenotype. Wortmannin has been previously demonstrated to act as a radiosensitizer agent and, although wortmannin also impairs the function of other members of PI-3 kinase family such as ATM, the radiosensitization is clearly dependent in part on DNA-PK inhibition in intact cells (Sarkaria et al., 1998) .
We have shown that the increase in DNA-PK activity was due to an increase in the expression of the catalytic subunit, DNA-PKcs without modification of Ku activity or expression in radioresistant cells. These results suggest that the level of DNA-PKcs may be the limiting component of the holoenzyme activity. We further demonstrated that transfection of FGF-2 can upregulate transcription of the gene encoding DNA-PKcs. An analysis of the DNA-PKcs promoter reveals that it does not contain TATA or CCAAT box sequences but potential binding sites for transcription factors, in particular Sp1, features associated with house-keeping genes (Connelly et al., 1998; Fujimoto et al., 1997) . These features suggest that regulation of DNA-PK expression is not likely to occur frequently at transcriptional level.
However, it has been recently demonstrated for the first time that the regulation of DNA-PKcs transcription was modulated by the activation of Sp1 binding to the DNA-PKcs promoter after incubation of human fetal kidney cells with NO (Xu et al., 2000) . This study, in addition to our present results clearly demonstrates that up-regulation of DNA-PKcs expression controlled at transcriptional level might be observed in human cells. Similar induction of at least one transcription factor controlling DNA-PKcs transcription might occur with FGF-2. In fact, FGF-2 is able to activate various transcription factors. In osteoblast-like cells, the zinc-finger transcription factor Egr-1 binding activity is regulated by FGF-2. The binding and transcriptional activities of multifunctional transcription factor Yin-Yang-1 (YY1) were enhanced by FGF-2 in smooth muscle cells (Santiago et al., 2001) . FGF-2 also regulates the serum response factor (SRF) promoter by two mechanisms involving either an ETS binding site or a Sp1 binding portion (Spencer et al., 1999) . Furthermore, nuclear 24 kDa FGF-2 can interact with the protein kinase CK2 (Bonnet et al., 1996) , the ribosomal protein L6/TaxREB107 (Shen et al., 1998b) and with the anti-apoptotic factor FIF (Van den et al., 2000) . Several reports have suggested that CK2 is able to control transcription by phosphorylating transcription factors (Grein and Pyerin, 1999; Guo et al., 1999; Zhou et al., 2001) . L6/TAXREB107 mediates the DNA binding of the HTLV-1 transactivator Tax (Shen et al., 1998b) . These data indicate that the activation of DNA-PKcs transcription in HeLa 3A cells could be due to FGF-2-mediated increased binding of specific transcription factors to DNA-PKcs promoter. Further works are necessary to define the biological partners of nuclear 24 kDa FGF-2 that are involved in the activation of DNA-PKcs transcription.
The fact that the 24 kDa FGF-2 isoform leads to an increase in expression, and therefore activity of DNAPKcs might be relevant to a clinical application. It is interesting to note that FGF-2 appears to be more abundant in human glioma that exhibit a poor response to radiotherapy. In addition, abundant mRNA expression of FGF-2 is detected in human gliomas whereas its expression is undetectable in normal brain samples (Takahashi et al., 1990) . Overexpression of FGF-2 correlates with the grade of the glioma and the extent of anaplasia (Zagzag et al., 1990) . In glioma tumors, FGF-2 is overexpressed in the nuclei of neoplasic cells (Stachowiak et al., 1997) . These data and our present result suggest that the quantification of the DNA-PKcs activity might constitute a predictive test for response to radiotherapy in FGF-2 expressing tumors. Further experiments are clearly needed to evaluate the role of FGF-2 mediated increase in DNA-PK activity in the radioresistance of primary human brain tumors.
In conclusion, we have demonstrated here that the expression of 24 kDa FGF-2 results in upregulation of DNA-PKcs and protection against IR induced toxicity due to an increased capacity to repair DNA DSBs. Further investigations are currently developed in our laboratory to determine the biological pathways controlled by FGF-2 leading to the up-regulation of DNA-PKcs expression. The understanding of this pathway may be relevant to the development of new approaches in the treatment of radioresistant human tumors expressing growth factors.
Materials and methods
Reagents DMEM, calf serum, G418 and all other culture reagents were purchased from GIBCO Life Technologies SARL (Cergy Pontoise, France). Zeocine was from Cayla (Toulouse, France), Horseradish peroxidase labeled goat anti-rabbit IgG was from Biorad (Ivry/Seine, France). Anti Ku 70 (N3H10) anti-Ku 80 (111) and anti-DNA-PKcs (18.2) were from Neomarkers (Fremont, CA, USA) and anti-XRCC4 from Argene (France); anti-ligase IV was a generous gift from T Lindahl (London, UK). Anti-mouse horseradish peroxidase was from Pierce. Nitrocellulose and non-fat dried milk protein from Biorad (Ivry/Seine, France). ECL system and Hyperfilm MP were obtained from Amersham (les Ulis, France). Cells were irradiated with a clinical cobalt 60 machine (Theratronics 1000, A.E.C.L., Ottawa, Canada).
Cell culture
HeLa cells were grown in DMEM supplemented with 5% fetal calf serum (FCS) at 378C in a 5% CO 2 -humidified incubator. HeLa PINA cells were transfected with the mammalian retroviral expression vector PINA. Hela 3A cells were obtained (Estival et al., 2001) . CAPAN-1 cells were transfected with the empty vector PINA and used as control.
DNA-PK assay
Kinase assays were performed as described previously (Finnie et al., 1995) with some modifications (Muller et al., 1998a) . Each sample was assayed in the presence of either DNA-PK specific peptide substrate (SQE peptide: EPPLSQEA-FADLWKK) or a negative control peptide (SEQ peptide: EPPLSEQAFADLWKK). To determine DNA-PK activity the value of the signal obtained with the SQE peptide was subtracted from that for the SEQ peptide, then the ratio c.p.m. FGF-2 transfected cells/c.p.m. empty vector transfected cells was quantified.
Protein extract preparation and Western blotting
Whole cell extracts were prepared by a modification of the method of Finnie et al. (1995) . Briefly, 5.10 6 cells were harvested, washed three times in phosphate-buffered saline and the cell pellets were frozen at 7808C. Frozen cell pellets were resuspended in extraction buffer (50 mM NaF, 20 mM HEPES pH 8, 450 mM NaCl, 25% v/v glycerol, 0.2 mM EDTA, 0.5 mM DTT, 0.5 mM PMSF, 0.5 mg/ml leupeptin, 0.5 mg/ml protease inhibitor and 1.0 mg/ml trypsin inhibitor), subjected to three freeze/thaw cycles (liquid nitrogen/378C), and centrifuged at 8000 g for 10 min at 48C. Supernatants were stored at 7808C prior to use and protein concentrations were determined by Bradford's method. Protein extracts from cells (20 mg) were resolved by SDS-polyacrylamide gel electrophoresis and transferred to a nitrocellulose membrane. Then, the membranes were hybridized with antibodies and revealed.
Electrophoretic mobility shift assay (EMSA)
A radiolabeled double-stranded 25-mer DNA probe was prepared according to Han et al. (1996) . EMSA was performed as described previously (Zhang and Yaneva, 1992) . The samples underwent electrophoresis on a 5% polyacrylamide gel for 2 h at 1008C. Gel was dried on Whatman 3MM paper and autoradiographed with Kodak X-OMAT films.
RPA assay
Total RNA were extracted from HeLa PINA and HeLa 3A using Trizol according to the manufacturing conditions. Riboprobes for hybridization were prepared from DNAPKcs and 36B4 cDNA fragments cloned in pKS vector using T3 polymerase (Promega) and a[
33 P]UTP (3000 Ci/mMol; ICN). Ribonuclease protection assay was performed using 20 mg of total RNA with the RPA III kit (Ambion) as described by the supplier. The amount of hybridized probe was quantified using Phosphor Imager (Molecular Dynamics, USA). The amount of DNA-PKcs mRNA was quantified by determining the ratio of the signal obtained with DNA-PKcs probe to that of 36B4.
Transient transfections and luciferase assays
Transient transfections of HeLa 3A and HeLa PINA cells were performed using the LipofectAMINE TM Reagent plus method following the manufacturer's instructions (Life Technology). Cells were co-transfected with the DNA-PKcs promoter reporter plasmid p507 containing positions 73 to 7666 of the DNA-PKcs promoter kindly given by Dr Carl Anderson (Brookhaven laboratory, New York, USA), and the internal control plasmid pRL-CMV expressing Renillia luciferase under the control of pCMV promoter (Promega). Relative firefly luciferase activity due to the induction of DNA-PKcs promoter was calculated by dividing the firefly reading by the Renillia luciferase value.
DNA repair analysis
Cells were seeded into 140-mm Petri dishes and labeled in growth medium with 6-[ 3 H]thymidine (2.0 mCi/ml; 25 Ci/ mmol) (Amersham Pharmacia Biotech) for 24 h. They were then trypsinized and 3.10 5 cells were seeded into 60-mm Petri dishes in growth medium with 6-[ 3 H]thymidine (2.0 mCi/ml; 25.0 Ci/mmol) for 24 h. The cells were then irradiated at the indicated doses. At various times after irradiation the cells were trypsinisated, suspended in cold PBS, centrifuged at 500 g for 10 min and the pellets mixed with 0.7% low melting agarose (Sigma). The liquid suspension was transferred into rectangular 180 ml moulds and was allowed to solidify at 48C for 10 min. The plugs were transferred to Eppendorf vials with lysis solution (0.2 M EDTA, 1 mg/ml Proteinase K, 1% SDS). Digestion was performed for 24 h at 488C. Subsequently, the plugs were washed three times in 0.2 M EDTA. Each plug was loaded onto a 0.8% agarose gel (high strength analytical grade; Bio-Rad). The gels were run in TBE1X buffer with constant electric fields of different strengths. In a first step, 0.6 V/cm for 36 h then 1.5 V/cm for 7 h, 3 V/cm for 90 min and 9 V/cm for 30 min. Each lane of the gel was sliced into two parts corresponding to broken DNA and unbroken DNA. The pieces were melted at 1008C and immediately mixed with scintillation liquid for scintillation counting. Data were presented as the percentage fraction of activity released (FAR) remaining at indicated times, as previously described (Foray et al., 1997) .
Radiation survival determination
The effect of wortmannin on the radiosensitivity of HeLa 3A cells was assessed with a clonogenic assay. Cells from an exponential culture were plated out at 2000 cm 2 dishes, in duplicate, and allowed to attach for 4 h. They were pretreated with various doses of wortmannin or DMSO (vehicle) for 2 h and then irradiated at different doses. Irradiation was carried out with a clinical cobalt-60 machine (Theratronics 1000, A.E.C.L., Ottawa, Canada) at a dose rate of 65 cGy/min. Sixteen hours after irradiation, the cells were washed with three complete changes of medium to remove the wortmannin. Survival after irradiation was defined as the ability of the cells to maintain their clonogenic ability and to form colonies as already described for HeLa cells (CohenJonathan et al., 1997) . The best fit survival curve was generated according to the linear quadratic model and the mean activation dose (MID) calculated (Fertil et al., 1984) . 
Statistical test
Student's t-test was performed to compare various mean values.
